GLOW
70 mg
€ 100,00
per vialComing soonGLOW — 70 mg per research vial: GHK-Cu 50 mg, TB-500 10 mg and BPC-157 10 mg. For research purposes only. Not for human consumption or therapeutic use.
- Reference
- MVP / 007
- Strength
- 70 mg
- Availability
- Coming soon
- Handling
- Store cool and dry, away from light. Laboratory handling only.
- Shipping
- PostNL within the Netherlands, € 4,99 per order
Specification
For research only. Not for human use.
Key research areas
- Tri-peptide blend interactions (GHK-Cu, TB-500, BPC-157)
- Fibroblast and collagen-process biology
- Cell migration in connective-tissue models
- Cytoskeletal and actin-related mechanisms
- Skin- and tissue-research frameworks
Potential benefits observed in research
- GHK-Cu component is linked in research to collagen synthesis and skin-quality markers.
- BPC-157 and TB-500 components are studied for cell-migration and tissue-response effects.
- Provides a combined subject for exploring recovery-pathway interactions.
- Component findings include antioxidant and matrix-support observations.
Reported observations from published studies under controlled conditions. They do not establish the safety, quality or performance of this research material.
Research documentation
GLOW — 70 mg
GLOW combines GHK-Cu 50 mg, TB-500 10 mg and BPC-157 10 mg, providing a stated total of 70 mg per vial. Its components connect several areas of connective-tissue and cellular research. GHK-Cu, a copper-binding tripeptide, has been investigated in fibroblast and collagen studies. BPC-157 has been examined in laboratory and animal models involving tendon-cell migration and survival. TB-500 is associated with thymosin beta-4 fragment research, where exact molecular identity determines which findings are relevant. The combination creates a subject for investigating interactions between these research pathways.
Key Research Areas
- Fibroblast biology
- collagen processes
- cell migration
- peptide interactions
However, evidence on separate components does not establish synergy, improved recovery or clinical benefit for this blend. No human therapeutic effect is established for the MVP formulation. GHK-Cu research; BPC-157 research; TB-500 identity review.
For research purposes only. Not for human consumption or therapeutic use.
